We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Enhanze technology is based on Halozyme’s patented recombinant human hyaluronidase enzyme (rHuPH20) that removes traditional limitations on the volume of biologics that can be delivered subcutaneously.